Beyond genomics
New technologies are transforming how we tackle global health challenges, from infectious disease threats such as coronavirus, MRSA and Ebola to the burdens of cancer, heart disease and dementia
We focus on new and emerging scientific opportunities for health, such as the power of AI to harness the wealth of data generated by genomics and ‘omics technologies. Our analyses of the potential impact of such tools on health services and society let us provide practical and realistic policy guidance grounded in sound science, law and ethics alongside medical needs and human concerns.
Research Assessing AI for early detection of oesophageal cancer
A collaboration between the Universities of Cambridge, Oxford, Kings College London, the PHG Foundation and Cyted.
Report Citizen generated data and health: predictive prevention of disease
With increasing digitisation it is time to consider how data, collected from outside the health system, can improve the effective delivery of healthcare
Blog Putting AI to work against COVID-19
20 April 2020
What use AI in the face of the massively disruptive effects of a serious infectious disease outbreak?
Consultation response Department for Digital, Culture, Media & Sport: Data Protection
The PHG Foundation welcomes the opportunity to comment on the DCMS consultation on reforms to the UK data protection regime.
Explainer Host genomics and infectious disease
Genomic factors can explain why different people (hosts) may have more or less severe symptoms or no symptoms when infected by the same pathogen.
Explainer Digital twins
The digital twin is an engineering concept which is gaining attention in healthcare.
Research Assessing AI for early detection of oesophageal cancer
23 September 2021
A collaboration between the Universities of Cambridge, Oxford, Kings College London, the PHG Foundation and Cyted.
Blog Economies of scale: Genetically-targeted therapies
15 September 2021
The genomics revolution has given us an exceptional understanding of what genes do, how they are expressed (turned on or off), and what happens when they don’t work as they should.
Explainer Pharmacogenomics
16 August 2021
What is pharmacogenomics?
Blog Challenging assumptions about technology and ageing
10 August 2021
A new inquiry by the Nuffield Council on Bioethics is examining the ethical issues posed using biomedical research and technology in helping people live better in old age.
Explainer Microbiome analysis and manipulation
27 July 2021
A short overview of the potential healthcare uses of understanding the microbiome
Blog What does ‘good governance’ look like for genome editing?
21 July 2021
PHG Policy Analyst, Tanya Brigden, usefully summarises the recommendations for the WHO's considerations towards genome editing
Blog Making the UK a science superpower
28 June 2021
The recent and abrupt change in Secretary of State for Health for the UK has overshadowed some very significant policy developments over the last week.